POST Online Media Lite Edition



 

Perrigo buys scar management brand ScarAway

Staff writer |
Intrepid Investment Bankers announced the acquisition of ScarAway, an over-the-counter (OTC) scar management brand, from its client Enaltus by Perrigo Company.

Article continues below






Enaltus is a portfolio company of HealthEdge Investment Partners.

“Intrepid understood the value drivers and brand value of the ScarAway brand from the outset. They ran a terrific process, resulting in the right acquiror for ScarAway and a great result for Enaltus and HealthEdge,” said Jeff Thompson, CEO of Enaltus and Partner at HealthEdge.

“We were impressed with the brand’s market leadership position, strong physician support network, and multi-channel presence—and we knew ScarAway would generate a great deal of interest,” added Steve Davis, Managing Director and Head of the Beauty & Personal Care practice at Intrepid.

ScarAway is the fastest growing brand in the category and is currently the No. 1 100% silicone scar treatment brand and the No. 2 brand in the overall consumer scar category in the U.S. ScarAway has distribution across all the leading retailers in the drug, mass, food, specialty and ecommerce channels with a presence in more than 35,000 doors in the U.S.


What to read next

Perrigo completes acquisition of OTC brands from GSK
Perrigo CEO: Mylan's hostile takeover would cause chaos
Mylan now says Perrigo is not a must...